SCHEMBL1284634

SCHEMBL1284634

Cc1ccc(C=CC(O)(Cn2cncn2)C(C)(C)C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HSP90AA1 P07900 3/20 0.42
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
FDPS P14324 1/20 0.38
CYP19A1 P11511 4/20 0.37
LMNA P02545 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
ADRA1A P35348 1/20 0.37
CYP51A1 Q16850 1/20 0.37
KMT2A Q03164 4/20 0.36
KDM4E B2RXH2 2/20 0.33
RAB9A P51151 1/20 0.33
ATM Q13315 1/20 0.33
AR P10275 1/20 0.32
PTGS1 P23219 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1284632 1.00 CYP3A4 (0.43) CYP3A4ALDH1A1HSP90AA1CYP2C19CYP1A2
SCHEMBL9788463 0.89 KMT2A (0.49) CYP3A4ALDH1A1HSP90AA1CYP2C19CYP1A2
SCHEMBL9443155 0.89 ALDH1A1 (0.56) CYP3A4ALDH1A1HSP90AA1CYP2C19FDPS
SCHEMBL9788438 0.89 KMT2A (0.49) CYP3A4ALDH1A1HSP90AA1CYP2C19CYP1A2
SCHEMBL9443025 0.89 ALDH1A1 (0.56) CYP3A4ALDH1A1HSP90AA1CYP2C19FDPS
SCHEMBL9443020 0.89 ALDH1A1 (0.56) CYP3A4ALDH1A1HSP90AA1CYP2C19FDPS
SCHEMBL10744398 0.83 ALDH1A1 (0.41) CYP3A4ALDH1A1HSP90AA1CYP2C19FDPS
SCHEMBL10745733 0.82 CYP3A4 (0.37) CYP3A4ALDH1A1HSP90AA1CYP2C19FDPS
SCHEMBL10745738 0.82 CYP3A4 (0.37) CYP3A4ALDH1A1HSP90AA1CYP2C19FDPS
SCHEMBL10518216 0.81 CYP3A4 (0.40) CYP3A4ALDH1A1HSP90AA1CYP2C19FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443099-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES HAVING A 5- SULFUR SUBSTITUENT BASF SE (DE) 2012-04-25 EP disclosed
US-20120088664-A1 Antifungal 1,2,4-triazolyl derivatives having a 5-sulfur subtituent BASF SE (DE) 2012-04-12 US disclosed
WO-2010146113-A1 ANTIFUNGAL 1, 2, 4-TRIAZOLYL DERIVATIVES HAVING A 5- SULFUR SUBSTITUENT BASF SE (DE) 2010-12-23 WO disclosed
US-5041459-A Plant diseases; protection of industrial materials BAYER AKTIENGESELLSCHAFT (DE) 1991-08-20 US disclosed
EP-0405264-A1 Hydroxy-keto-azoles BAYER AG (DE) 1991-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088664-A1 Antifungal 1,2,4-triazolyl derivatives having a 5-sulfur subtituent STS, TST, ERG28 CYP3A4 49/4885ALDH1A1 1568/4885HSP90AA1 2248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.